research

Regulatory withdrawal of medicines marketed with uncertain benefits : the bevacizumab case study

Authors
Publication date
1 January 2015
Publisher
'Springer Science and Business Media LLC'
Doi
    View on PubMed

    Abstract

    Acknowledgements Professor Elizabeth Roughead is funded by a Future Fellowship from the Australian Research Council. The views expressed are those of the authors, the sponsor had no role in the preparation of the manuscript.Peer reviewedPublisher PD

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1186%2Fs40545-015-...
      Last time updated on 01/04/2019

      The Open University

      redirect
      oaioai:aura.abdn.ac.uk:2164/5095
      Last time updated on 17/02/2016